- 2021 - 2026 Development of innovative AI methods for predicting therapeutic targets for intractable diseases from medical big data
- 2022 - 2025 皮膚恒常性維持シグナルを標的とした慢性炎症性皮膚疾患治療基盤構築
- 2020 - 2023 molecular design and action mechanism of peptidomimetics using natural products-like cubic scaffolds
- 2019 - 2022 Investigation of skin homeostasis based on the regulation of actin cytoskeleton
- 2017 - 2020 Identification of target molecules and functions of Tomosaponin AIII
- 2016 - 2019 Ligand-independent roles of ErbB recepotors on the regulation of cell-cell adhesion
- 2014 - 2017 Physiological roles and action mechanisms of mDia-induced actin cytoskeleton in the body
- 2014 - 2017 GDP-bound Rab27a regulates endocytosis by mediating vATPase-dependent regulation of pH
- 2014 - 2017 Identification and functional analysis of substrates of disease-associated protein kinases using multiple phosphoproteomic technologies
- 2013 - 2016 Roles of mDia, an actin nucleation factor, in cell transformation
- 2014 - 2015 mDiaが紡ぐアクチン細胞骨格の個体生理での役割と分子メカニズムの解析
- 2013 - 2015 構造情報を活用した細胞質分裂の分子メカニズムの解明
- 2011 - 2013 細胞質分裂におけるRhoシグナル伝達分子複合体の構造および機能解析
- 2011 - 2012 The role of mDia, a Rho effector molecule, in tumorigenesis
- 2006 - 2007 Functional interaction between Rho effector proteins
- 2006 - 2007 細胞接着に果たすRho標的蛋白質の役割と細胞悪性化への寄与
- 2001 - 2001 Rho標的蛋白質による細胞悪性化と細胞移動の分子機序の解析
- 2000 - 2001 Signal Crosstalk between Rho and Tyrosine phosphorylation
- 2000 - 2000 Rho標的蛋白質ROCKキナーゼによる細胞悪性化の分子機序の解明
- 1996 - 2000 Signal Transduction and Cellular Functions of the Small GTPase Rho and its Effectors
- 1998 - 1999 The molecular mechanism of p160ROCK-mediated signaling pathway
Show all
